| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/03/2007 | EP1738756A2 Esmolol formulation |
| 01/03/2007 | EP1738755A1 Tablet containing branched chain amino acid and process for producing the same |
| 01/03/2007 | EP1738754A1 Solid pharmaceutical preparation |
| 01/03/2007 | EP1738751A2 Spaced drug delivery system |
| 01/03/2007 | EP1738749A1 Pharmaceutical compositions providing enhanced drug concentrations |
| 01/03/2007 | EP1738657A2 Sugar alcohol composition for tableting |
| 01/03/2007 | EP1737961A1 Modified bouganin proteins, cytotoxins and methods and uses thereof |
| 01/03/2007 | EP1737948A2 Methods of promoting cardiac cell proliferation |
| 01/03/2007 | EP1737869A1 Regiospecific synthesis of rapamycin 42-ester derivatives |
| 01/03/2007 | EP1737500A1 Bioresponsive polymer system for delivery of microbicides |
| 01/03/2007 | EP1737497A2 Nucleic acid aptamers conjugated to high molecular weight steric groups |
| 01/03/2007 | EP1737496A2 Novel g-csf conjugates |
| 01/03/2007 | EP1737495A1 Novel pharmaceutical or cosmetic carriers containing cylcic acetals |
| 01/03/2007 | EP1737494A2 Freeze-dried, free-flowing, particulate composition having improved palatability |
| 01/03/2007 | EP1737455A1 Controlled release pharmaceutical composition of tolperisone for oral administration |
| 01/03/2007 | EP1737441A2 Beneficial effects of increasing local blood flow |
| 01/03/2007 | EP1737429A1 Transdermal delivery of beneficial substances effected by a hostile biophysical environment |
| 01/03/2007 | EP1737428A1 Macromolecular delivery systems for non-invasive imaging, evaluation and treatment of arthritis and other inflammatory diseases |
| 01/03/2007 | EP1737427A2 Nucleotide-cochleate compositions and methods of use |
| 01/03/2007 | EP1660099A4 Intravascular delivery of non-viral nucleic acid |
| 01/03/2007 | EP1658273B1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 01/03/2007 | EP1551364B1 Thickener compositions comprising sclerotium gum and a copolymer |
| 01/03/2007 | EP1485098B1 Pharmaceutical compositions comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo¬1,5-b|pyridazine in nanoparticulate form |
| 01/03/2007 | EP1476467B9 Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same |
| 01/03/2007 | EP1463487A4 Liposomal delivery of vitamin e based compounds |
| 01/03/2007 | EP1448221B1 Injection solution comprising an lhrh antagonist |
| 01/03/2007 | EP1448168B1 Pharmaceutical formulation comprising bicalutamide |
| 01/03/2007 | EP1429731B1 Nanoparticulate insulin formulations |
| 01/03/2007 | EP1411903A4 Biodegradable polyhydric alcohol esters |
| 01/03/2007 | EP1411889B1 Cream for treatment of skin injured by the sun |
| 01/03/2007 | EP1390403B1 Peptides derived from neural thread proteins and their medical use |
| 01/03/2007 | EP1377315B1 Pharmaceutical compositions of rapmycins |
| 01/03/2007 | EP1355626B1 Veterinary dermatologic composition |
| 01/03/2007 | EP1347780B1 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides |
| 01/03/2007 | EP1322292B1 Microparticle compositions and methods for the manufacture thereof |
| 01/03/2007 | EP1278515B1 Pharmaceutical formulation comprising carrier beads coated with a layer of valaciclovir |
| 01/03/2007 | EP1274750A4 Hydrophilic polymers, pressure sensitive adhesives and coatings |
| 01/03/2007 | EP1267845B1 Plaster containing an active agent |
| 01/03/2007 | EP1267826B1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 01/03/2007 | EP1231914B1 Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 01/03/2007 | EP1221865B1 Food supplement for increasing lean mass and strength |
| 01/03/2007 | EP1212071B1 Stable carotene-xanthophyll beadlet compositions and methods of use |
| 01/03/2007 | EP1173765B1 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 01/03/2007 | EP1154756B1 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 01/03/2007 | EP1105108B1 Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture |
| 01/03/2007 | EP1049470B1 Extended release tiagabine formulations with reduced side-effects |
| 01/03/2007 | EP1024794B1 Methods of treating capsules and dry, powdered pharmaceutical formulations |
| 01/03/2007 | EP0942996B1 Thrombolytic agents with antithrombotic activity |
| 01/03/2007 | EP0896626B1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
| 01/03/2007 | EP0863768B1 Covalent heparin-protein conjugates comprising an alpha-carbonyl amine bond and methods of obtaining them |
| 01/03/2007 | CN1890295A Coordination complex of diaminocyclohexaneplatinum(II) with block copolymer containing poly(carboxylic acid) segment and antitumor agent comprising the same |
| 01/03/2007 | CN1890278A Copolymers based on tert-butyl(meth)acrylate and use thereof |
| 01/03/2007 | CN1890256A Aqueous suspensions of ciclesonide for nebulisation |
| 01/03/2007 | CN1889971A Pharmaceutical formulations for the sustained release of interferons and therapeutic applications thereof |
| 01/03/2007 | CN1889965A Use of biocompatible polymers for the preparation of a composition or a medical device |
| 01/03/2007 | CN1889942A Drug containing (2R)-2-propyloctanoic acid as the active ingredient |
| 01/03/2007 | CN1889941A Infusion preparation containing (2r)-2-propyloctanoic acid as the active ingredient |
| 01/03/2007 | CN1889930A Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof |
| 01/03/2007 | CN1887943A Filming gel composition and its use |
| 01/03/2007 | CN1887348A Inactivated chicken shigalla vaccine and its prepn |
| 01/03/2007 | CN1887291A Clorfarabine composition |
| 01/03/2007 | CN1887288A Medicine for treating endometriosis and its prepn |
| 01/03/2007 | CN1887282A Medicine composition containing bailobalide |
| 01/03/2007 | CN1887280A Application of saturated fatty polyol or alcoholic acid as cross-linking agent in filming gel composition |
| 01/03/2007 | CN1887278A Slow released doxazosin mesilate capsule and its prepn process |
| 01/03/2007 | CN1887277A Dispersant tablet containing hypolipidemic component and its prepn process |
| 01/03/2007 | CN1887276A Frozen phase separating process of preparing polysaccharide vitreous particle |
| 01/03/2007 | CN1887275A Prepn process of polysaccharide vitreous particle carrying active vaccine or antibody |
| 01/03/2007 | CN1887274A Prepn process of slow released microsphere of protein-polysaccharide vitreous particle |
| 01/03/2007 | CN1887273A Prepn process of polysaccharide vitreous particle |
| 01/03/2007 | CN1887272A Slow released dry azithromycin suspension and its prepn |
| 01/03/2007 | CN1887271A Azithromycin liposome composition medicine and its prepn process |
| 01/03/2007 | CN1887270A Nanometer berberine hydrochloride emulsion and its prepn process |
| 01/03/2007 | CN1887269A Slow released anticancer injection containing bendamustine and its synergist |
| 01/03/2007 | CN1887268A Slow released anticancer injection |
| 01/03/2007 | CN1887267A Slow released anticancer prepn with angiogenesis inhibitor and bendamustine |
| 01/03/2007 | CN1887266A Slow released compound anticancer prepn |
| 01/03/2007 | CN1887265A Slow released anticancer prepn |
| 01/03/2007 | CN1887264A Slow released compound anticancer prepn containing bendamustine |
| 01/03/2007 | CN1887263A Slow released compound anticancer injection containing bendamustine |
| 01/03/2007 | CN1887262A Slow released anticancer medicine injection containing bendamustine and its synergist |
| 01/03/2007 | CN1887261A Slow released compound anticancer injection containing bendamustine |
| 01/03/2007 | CN1887260A Slow released compound anticancer injection containing clorfarabine |
| 01/03/2007 | CN1887259A Slow released compound anticancer prepn containing clorfarabine |
| 01/03/2007 | CN1887258A Slow released compound anticancer injection containing clorfarabine |
| 01/03/2007 | CN1887256A AIDS treating kadeli'an amine injection and freeze dried powder for injection and their prepn |
| 01/03/2007 | CN1887255A Compound taurine injection and its prepn process and use |
| 01/03/2007 | CN1887254A Precursor micelle prepn and its production process |
| 01/03/2007 | CN1887253A Intelligent' gel and its application in contraception |
| 01/03/2007 | CN1293051C Diaminedithiol derivatives and radiorhenium or radoitechnetium complex thereof; liver cancer-treating composition comprising radiorhenium complex and lipiodol; and kit for preparation of liver cancer |
| 01/03/2007 | CN1292802C Therapeutical solution for nuring wound and dressing material used with the theraputical solution |
| 01/03/2007 | CN1292796C Controlled release composition and method of producing the same |
| 01/03/2007 | CN1292756C Effervescence tablet preparation for replenishing nutritious elements to human being and its preparation method |
| 01/03/2007 | CN1292746C Pharmaceutical composition administered orally comprising amino-sulfonyl-containing active compound (COX-2 inhibitors), polyethylene glycol and antioxidate |
| 01/03/2007 | CN1292745C The treatment of respiratory diseases |
| 01/03/2007 | CN1292743C Coated solid hyponotic |
| 01/03/2007 | CN1292742C Opioid formulations having extended controlled release |
| 01/03/2007 | CN1292721C Drug delivery device |
| 01/03/2007 | CN1292655C Stable liquid pharmaceutical formulation of IgG antibodies |
| 01/02/2007 | USRE39456 Radioactive embolizing compositions |